Notice of Intent for 1800 NEXGEN Cages with Clear High Temperature Polysulfone Plastic
ID: NOI-NIAID-25-2250675Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

All Other Miscellaneous Fabricated Metal Product Manufacturing (332999)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/3e1fdd04653c40f7810d8c25115550cc/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Allentown LLC for the procurement of specialized laboratory equipment. The requirement includes 50 units of the 1800 NEXGEN cages made from clear high-temperature polysulfone plastic, along with 50 external bottle tops designed for rat use, featuring dual pockets and various enhancements for research applications. This procurement is critical for supporting ongoing research efforts, as the specified items are tailored to meet unique laboratory needs that only Allentown LLC can fulfill. Interested vendors may submit capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 27, 2024, at 10:00 AM, with all submissions considered by the Government at its discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.

    Point(s) of Contact
    Leah Hinson
    leah.hinson@nih.gov
    Files
    Title
    Posted
    2_2250675_NOI.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Pre-Solicitation Notice indicating its intent to negotiate exclusively with Allentown LLC for specific laboratory supplies. These include 50 units of a high-temperature polysulfone plastic cage and 50 external bottle tops with various features tailored for research. The delivery location for these items is Hamilton, MT. This notice, issued under 41 U.S.C. 1901 (a) (1), advocates for a sole source acquisition due to the unique requirements that only this vendor can meet. While this notice is not a request for proposals, interested responsible parties can submit a capability statement by December 27, 2024, via the NIAID's eSASS portal. The Government will consider all timely submissions, but the decision to proceed with a competitive process rests solely with them.
    Similar Opportunities
    Notice of Intent for Laboratory Casework System
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is issuing a Notice of Intent for a sole source procurement of a Laboratory Casework System from Innovative Laboratory Systems. The requirement includes modular, durable, and customizable laboratory furniture that adheres to NIH Design Requirements Manual specifications and biosafety standards, ensuring it can withstand the demands of a research environment. The selected contractor will be responsible for delivery and installation services, maintenance support, and providing tailored training materials for laboratory staff, with the delivery location set for Hamilton, Montana. Interested parties capable of providing similar services must submit a capability statement by December 30, 2024, to Leah Hinson at leah.hinson@nih.gov, as the government intends to negotiate without full and open competition based on the authority of 41 U.S.C. 1901 (a) (1) and FAR 13.106-1.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    In-VitroCell NU-5710 Direct Heat CO2 Incubator
    Active
    Health And Human Services, Department Of
    Combined Synopsis/Solicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking to procure an In-VitroCell NU-5710 Direct Heat CO2 Incubator. This item is typically used for laboratory research and is intended to replace the current incubators being utilized at NIEHS. The procurement is being conducted on a sole source basis with Nuaire, Inc. The delivery date for this purchase is September 30, 2024. Interested parties may submit a capability statement by July 25, 2024, 5:00 PM EST. For more information, please contact Brian Moyer at moyerbd@niehs.nih.gov.
    Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Leica Microsystems Inc. for a 12-month renewal Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444), with two optional one-year extensions. The procurement aims to secure a comprehensive maintenance agreement that includes unlimited service visits by trained engineers, OEM replacement parts, annual planned maintenance, and access to expert support, ensuring the microscope operates at optimal performance levels. This equipment is crucial for research and diagnostics in the field of allergy and infectious diseases, highlighting the importance of maintaining its functionality. Interested vendors must submit capability statements by 10:00 AM EST on December 30, 2024, through the NIAID electronic Simplified Acquisition Submission System (eSASS), with all required documentation to be included for consideration.
    Brand Name Biological Product
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a brand name biological product under solicitation number RFQ-NIAID-25-2251721. The procurement involves the acquisition of specific biological supplies, including various anti-human antibodies, to support the National Institute of Allergy and Infectious Diseases (NIAID) in its research efforts. These products are critical for advancing biomedical research and ensuring the availability of high-quality reagents for scientific studies. Interested vendors must submit their offers by December 22, 2024, at 10:00 AM EST, and can direct inquiries to Calvin Robinson at calvin.robinson@nih.gov.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    THERMO ELECTRON ESSENTIAL PLAN SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a service agreement with Thermo Electron North America, LLC for essential maintenance of scientific equipment. This procurement aims to secure a service agreement for critical mass spectrometry instruments used in advanced research applications, including the Orbitrap Fusion Lumos and FAIMS PRO, which are vital for the analysis and characterization of peptides and proteins. The instruments play a crucial role in enabling NIAID researchers to conduct high-precision studies in mass spectrometry and bioinformatics. Interested vendors must submit their capability statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 26, 2024, with further inquiries directed to Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    NOTICE OF INTENT FOR iSEQ 100 ADVANCE, Mi SEQ, AND NEXT SEQ 2000 SILVER SUPPORT PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source contract with Illumina for a Silver Support Plan covering specific laboratory equipment, including the Nextseq 2000 and MiSeq systems. This support plan includes comprehensive services such as full coverage for parts, labor, and travel, OEM parts and service, reagent replacement due to equipment failures, scheduled maintenance visits, remote technical support, and timely on-site response, all over a 12-month term billed quarterly. The procurement is critical for maintaining the operational efficiency of NIAID's laboratory capabilities, ensuring that essential equipment remains functional and supported. Interested vendors must submit their responses via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 23, 2024, at 10:00 AM EST, and should direct any inquiries to Leah Hinson at leah.hinson@nih.gov.